Form 8-K - Current report:
SEC Accession No. 0000950170-24-117568
Filing Date
2024-10-28
Accepted
2024-10-28 07:05:18
Documents
58
Period of Report
2024-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-20241028.htm   iXBRL 8-K 43430
2 EX-99.1 eypt-ex99_1.htm EX-99.1 41380
3 EX-99.2 eypt-ex99_2.htm EX-99.2 42727
4 GRAPHIC img96707757_0.jpg GRAPHIC 99780
5 GRAPHIC eypt-ex99_2s1.jpg GRAPHIC 179740
6 GRAPHIC eypt-ex99_2s2.jpg GRAPHIC 783830
7 GRAPHIC eypt-ex99_2s3.jpg GRAPHIC 203282
8 GRAPHIC eypt-ex99_2s4.jpg GRAPHIC 340439
9 GRAPHIC eypt-ex99_2s5.jpg GRAPHIC 389569
10 GRAPHIC eypt-ex99_2s6.jpg GRAPHIC 290895
11 GRAPHIC eypt-ex99_2s7.jpg GRAPHIC 349041
12 GRAPHIC eypt-ex99_2s8.jpg GRAPHIC 364237
13 GRAPHIC eypt-ex99_2s9.jpg GRAPHIC 463064
14 GRAPHIC eypt-ex99_2s10.jpg GRAPHIC 220993
15 GRAPHIC eypt-ex99_2s11.jpg GRAPHIC 414162
16 GRAPHIC eypt-ex99_2s12.jpg GRAPHIC 295979
17 GRAPHIC eypt-ex99_2s13.jpg GRAPHIC 395224
18 GRAPHIC eypt-ex99_2s14.jpg GRAPHIC 270488
19 GRAPHIC eypt-ex99_2s15.jpg GRAPHIC 320869
20 GRAPHIC eypt-ex99_2s16.jpg GRAPHIC 357817
21 GRAPHIC eypt-ex99_2s17.jpg GRAPHIC 357075
22 GRAPHIC eypt-ex99_2s18.jpg GRAPHIC 445981
23 GRAPHIC eypt-ex99_2s19.jpg GRAPHIC 196907
24 GRAPHIC eypt-ex99_2s20.jpg GRAPHIC 345440
25 GRAPHIC eypt-ex99_2s21.jpg GRAPHIC 342483
26 GRAPHIC eypt-ex99_2s22.jpg GRAPHIC 289558
27 GRAPHIC eypt-ex99_2s23.jpg GRAPHIC 283168
28 GRAPHIC eypt-ex99_2s24.jpg GRAPHIC 338014
29 GRAPHIC eypt-ex99_2s25.jpg GRAPHIC 523547
30 GRAPHIC eypt-ex99_2s26.jpg GRAPHIC 473977
31 GRAPHIC eypt-ex99_2s27.jpg GRAPHIC 293473
32 GRAPHIC eypt-ex99_2s28.jpg GRAPHIC 385382
33 GRAPHIC eypt-ex99_2s29.jpg GRAPHIC 200973
34 GRAPHIC eypt-ex99_2s30.jpg GRAPHIC 358047
35 GRAPHIC eypt-ex99_2s31.jpg GRAPHIC 356118
36 GRAPHIC eypt-ex99_2s32.jpg GRAPHIC 203851
37 GRAPHIC eypt-ex99_2s33.jpg GRAPHIC 331208
38 GRAPHIC eypt-ex99_2s34.jpg GRAPHIC 299085
39 GRAPHIC eypt-ex99_2s35.jpg GRAPHIC 341395
40 GRAPHIC eypt-ex99_2s36.jpg GRAPHIC 272349
41 GRAPHIC eypt-ex99_2s37.jpg GRAPHIC 184158
42 GRAPHIC eypt-ex99_2s38.jpg GRAPHIC 422858
43 GRAPHIC eypt-ex99_2s39.jpg GRAPHIC 338408
44 GRAPHIC eypt-ex99_2s40.jpg GRAPHIC 385850
45 GRAPHIC eypt-ex99_2s41.jpg GRAPHIC 194480
46 GRAPHIC eypt-ex99_2s42.jpg GRAPHIC 443324
47 GRAPHIC eypt-ex99_2s43.jpg GRAPHIC 392100
48 GRAPHIC eypt-ex99_2s44.jpg GRAPHIC 175623
  Complete submission text file 0000950170-24-117568.txt   20792121

Data Files

Seq Description Document Type Size
49 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eypt-20241028.xsd EX-101.SCH 23898
60 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20241028_htm.xml XML 4523
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 241398422
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)